GO2EC.ORG
Site Map
About Us EC & Pharmacies State Information Legislation Media Center Resources Get Involved
Helping pharmacy & health communities improve access to Emergency Contraception (EC)

Update Us On News In Your State

Update/Add Contact Info

Update/Share Resources

Share Your Personal Story

Home > State Profiles > Hawaii State Profile

Hawaii State Profile

EC PHARMACY UPDATE

Check out Hawaii’s new dedicated EC website, www.echawaii.org

The state Department of Health Services will begin to cover non-prescription Plan B for Medicaid recipients effective July 1, 2007. The Healthy Mothers Healthy Babies (HMHB) Coalition of Hawaii is working closely as community contacts/technical assistants with the state Medicaid office and the Director of Hawaii DHS to implement the OTC coverage for Medicaid recipients. HMHB is encouraging DHS to advertise the OTC coverage to all recipients when the change is implemented. HMHB has also recommended no payment caps on the amount of times a woman can obtain EC OTC. According to HMHB, a bill (HB 456) to address the same issue died in committee due to the recent DHS move. The bill would have required DHS to directly reimburse sellers of Plan B OTC to Medicaid enrollees.

On June 24, 2003, Governor Lingle signed HB 123 into law (ACT 201), enabling pharmacists who have received appropriate training and who are working in collaboration with a physician, to initiate emergency contraception drug therapy.  Hawaii’s successful effort had the backing of a diverse coalition of stakeholders, which was coordinated by the Healthy Mothers Healthy Babies (HMHB) Coalition of Hawaii. For a full account of Hawaii’s policy change click here. For an overview of Hawaii EC access through pharmacies, click here.

Healthy Mothers Healthy Babies continues to assess women’s access to EC in pharmacies as well as pharmacists perspectives on stocking, filling and initiating prescriptions for EC. Click here to view the most recent versions of the confidential survey on women accessing EC in pharmacies (PDF-56K) and the survey of pharmacists regarding EC (PDF-48K).

ACT 201 amends the definition of the “practice of pharmacy” to allow pharmacists to initiate emergency contraception drug therapy in accordance with a written collaborative agreement approved by the Hawaii Board of Pharmacy, between a licensed physician and a pharmacist who has received appropriate training.  

On July 17, 2003 the Hawaii Board of Pharmacy formed a working group to research, study and make recommendations to the Pharmacy Board regarding the collaborative agreement. The working group took additional time to solicit comments and recommendations from the public, and included these in the final draft of the collaborative agreement that was submitted to the Pharmacy Board for the Administrative Rules process in September 2003. 

The current Hawaii Administrative Rules process consists of 16 steps that include a lengthy review process by the Attorney General’s Office, Director’s Office, Legislative Reference Bureau, and scheduling public hearings etc. The proposed language for the Administrative Rules, regarding emergency contraception collaborative agreements, was approved by the Hawaii Board of Pharmacy on November 13, 2003. In early 2004 the rules were sent to the Director’s Office for review by the Director of DCCA. The Director mandated that the Hawaii Medical Association, Hawaii- ACOG Chapter, and the University of Hawaii School of Medicine (among others) review the collaborative agreement. 

Rulemaking had delayed implementation of the EC program, and the Women’s Legislative Caucus had urged the Department of Commerce and Consumer Affairs and the Board of Pharmacy for a quicker review.

The proposed Administrative Rules were reviewed by the Director’s Office, and the Hawaii State Board of Pharmacy/DCCA scheduled a public hearing for Tuesday, September 28, 2004 to hear concerns from the public to determine if the Administrative Rules are to move forward towards implementing ACT 201, or start the process over. Shortly after public concerns were heard, the Hawaii State Board of Pharmacy/DCCA voted to approve the draft Administrative Rules on EC access. A meeting of the EC Policy Committee and EC Access and Awareness Committee was scheduled for December 16, 2004 to plan the implementation of the bill. The agenda includes pharmacist training, physician participation, educational materials, and public awareness strategies. The Governor gave final approval on the Administrative Rules on December 17, 2004, and effective 12/25/04 pharmacists could provide EC under collaborative protocol.

There were over 15 individuals, local and national organizations that provided supportive testimony, and a few consumers who testified against the law being implemented. The Administrative Rules will now be forwarded onto the Attorney General and the Governor for signature. Once the final approval is given, Hawaii will begin to implement the new law, which will consist of training pharmacists and signing voluntary collaborative agreements between pharmacist and physicians, and continually building EC awareness and education. Currently the rules state that every protocol must be sent to the Department of Commerce and Consumer Affairs, permit a dispensing interval of 120 hours, and mandate a referral to another pharmacist if the EC pharmacist is not there.

In 2002 HMHB formed an EC Workgroup to promote a greater understanding of EC and the public benefits of EC in preventing unintended pregnancy and reducing abortion, particularly in teens. The workgroup had broad representation and in addition to community based organizations, over time it included representatives of the State Department of Health, the Hawaii Women’s Legislative Caucus, Hawaii Planned Parenthood, the Hawaii Women's Coalition and the Hawaii Pharmacists Association. Members of the work group were instrumental in drafting, reviewing and editing HB 123, and this group is now addressing the larger issues of actual implementation.

Hawaii developed a standardized EC collaborative agreement protocol that has agreement from major stakeholders, such as the Hawaii Medical Association, the John A. Burns School of Medicine at the University of Hawaii and the American College of Obstetricians and Gynecologists (ACOG) Hawaii Chapter. Once approved, the Board of Pharmacy will post the standardized protocol on a website. The Department of Health will compile signed collaborative agreements on an interim basis, so that information may be collected and used for evaluation/quality assurance purposes.

The implementation workgroup is also addressing: pharmacist training, physician training, public awareness and education, as well as pharmacist reimbursement for patient counseling for EC. The University of Southern California conducted training on Maui and Oahu for over 100 pharmacists and other providers in August 2003, and future pharmacist trainings are expected to occur on all islands.

The Department of Health, HMHB, and Hawaii Planned Parenthood and other organizations are also assisting in developing educational and promotional materials and referral resources. Both Planned Parenthood and Healthy Mothers Healthy Babies are actively seeking funds to support an integrated EC educational campaign. Meetings are planned to have the Hawaii Pharmacists Association and Department of Human Services as well as other a third party insurers to discuss pharmacist reimbursement for EC counseling.  The Hawaii Pharmacists Association is also examining policies to accommodate pharmacist refusal to dispense EC.

A variety of organizations, including the Hawaii Pharmacists Association, Department of Health, Kaiser Permanente Hawaii, Hawaii Planned Parenthood and Healthy Mothers Healthy Babies, also plan to be involved in promoting and supporting physicians and pharmacists signing collaborative agreements statewide.  In August 2003, the Healthy Mothers Health Babies Coalition of Hawaii surveyed physicians regarding EC. Survey results (DOC-32K) indicated that 62% of providers surveyed are interested in entering into a collaborative practice agreement with a pharmacist.

The largest pharmacy chain in Hawaii is Longs. In California, Longs has its own ACPE training program for emergency contraception. It is expected that Longs plans to be actively involved in implementing EC services into its Hawaii retail outlets. Kaiser Permanente Hawaii is also planning to implement EC access in its pharmacies statewide as well. Times, a chain supermarket, has also indicated interest in providing EC services.

For press coverage in this state, click here.

Back to top

CONTACTS

Catherine Takauye
Executive Director
Hawaii Pharmacists Association
P.O. Box 1510
Aiea, HI 96701
(808) 330-7738
Fax: (808) 488-8601
ctconsulting@hawaii.rr.com

Karen Mak, MPH, NP
Acting Section Supervisor, Family Planning Services Section
Hawaii State Department of Health
741 A Sunset Ave., Rm 100
Honolulu, HI 96816
808-733-9030
Fax: 808-733-8355

Barbara Kashiwabara
Director, Pharmaceutical Services
Kaiser Permanente Hawaii
501 Alakawa Street
Honolulu, HI 96817
808-432-5547
Fax: 808-432-5535
barbara.kashiwabara@kp.org

Les Krenk, RPh
President
Hawaii Pharmacists Association
53 Puunene Ave.
Kahului, HI 96732
808-877-6222
808-281-5416 (cell)
lesk@maui.net

Kari Wheeling
Project Coordinator
Healthy Mothers Healthy Babies
1500 S. Beretania Street, Rm 408
Honolulu, HI 96826
808-951-5805
info@hmhb-hawaii.org

Back to top

USEFUL LINKS

Hawaii’s Dedicated EC Website
www.echawaii.org

Hawaii Board of Pharmacy
www.state.hi.us/dcca/pvl/areas_pharmacy.html

Hawaii State Legislature
www.capitol.hawaii.gov

Planned Parenthood of Hawaii
www.plannedparenthoodhawaii.org

Healthy Mothers Healthy Babies Coalition of Hawaii
www.hmhb-hawaii.org

Back to top

PROTOCOL ENVIRONMENT

Optimal Environment: No Revision to Authority Necessary

Existing statutes and regulations would accommodate pharmacists’ initiation of emergency contraception, generally under a collaborative practice agreement (protocol) with a prescriber.

Pharmacist initiation of EC requires:

  • Development of protocol
  • Pharmacist completion of an EC training program, including ACPE programs, "curriculum based programs from an ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board of pharmacy"
  • MD authorization of protocol
  • File protocol with State Board of Pharmacy

Back to top

PHARMACY PRACTICE ACT

Pharmacy Practice Act Regulatory and Statutory Authority

Note: The text presented below has been prepared by the American Pharmacists Association for the Pharmacy Access Partnership and reflects legislation or regulation promulgated as of June 15, 2003.

HAWAII

Under a collaborate practice bill passed in 2002, pharmacists in virtually all clinical settings, health care facilities and community pharmacies were given the authority to provide a variety of patient-care services pursuant to patient-specific protocols developed collaboratively with prescribers, including physicians, surgeons, and registered nurses, and in concurrence with the facility administrator. The pharmacist must receive appropriate training and immunization certification as required by the policies, procedures, or protocols.

Those patient care services included, most notably:

  • ordering or performing routine drug therapy-related patient assessment
  • administering drugs and biologicals orally, topically, or by injection (with appropriate training), pursuant to a order,
  • administering immunizations by injection pursuant to a patient-specific order (if the pharmacist has received “appropriate training”)
  • initiating or adjusting medication dosage pursuant to the physician’s order or authorization (provided the pharmacist issues written notification to the physician or enters appropriate data in an electronic patient record system shared with the physician within 24 hours of modification.)

The scope of practice is outlined in the protocol, allowing for any drug therapy listed. Institutional pharmacies must identify the route of delivery for medications administered and maintain records for at least five years.

On June 26, 2003, the Governor signed into law Act 201 (HB123/SB958) explicitly authorizing pharmacists to “initiat[e] emergency contraception oral drug therapy in accordance with a written collaborative agreement approved by the board [of pharmacy], between a licensed physician and a pharmacist who has received appropriate training that includes programs approved by the American Council of Pharmaceutical Education (ACPE), curriculum-based programs from an ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board of pharmacy.” The statute does not require the protocol to be patient-specific, and it defines “emergency contraception” broadly to include any FDA-approved drug “used post-coitally . . to prevent pregnancy. . .”

Finally, the new law expanded the definition of contraceptive services by adding pharmacists to the list of authorized health care providers (including MDs, NPs, RNs, PAs, and nurse midwives) who can deliver contraceptive services.

Statutory authority: Provided in the definition of “practice of pharmacy,” 25 Haw. Rev. Haw. Rev. Stat. § 461-1, and related definitions Haw.Rev.Stat. §431:10A-116.6-7, 19 Haw. Rev. Stat. §323D-2, and 24 Haw. Rev. Stat. §432E-1)

Regulatory authority: No rules have been promulgated implementing these sections.

 

HAWAII STATUTE

TITLE 25 – PROFESSIONS AND OCCUPATIONS

CHAPTER 461

PHARMACISTS AND PHARMACY

19 Haw. Rev. Stat. §323D-2 Definitions. As used in this chapter:

“Health care facility” and “health care service” include any program, institution, place, building, or agency, or portion thereof, private or public, other than federal facilities or services, whether organized for profit or not, used, operated, or designed to provide medical diagnosis, treatment, nursing, rehabilitative, or preventive care to any person or persons. The terms include, but are not limited to, health care facilities and health care services commonly referred to as hospitals, extended care and rehabilitation centers, nursing homes, skilled nursing facilities, intermediate care facilities, hospices for the terminally ill that require licensure or certification by the department of health, kidney disease treatment centers including freestanding hemodialysis units, outpatient clinics, organized ambulatory health care facilities, emergency care facilities and centers, home health agencies, health maintenance organizations, and others providing similarly organized services regardless of nomenclature.

19 Haw. Rev. Stat. §432E-1 Definitions. As used in this chapter, unless the context otherwise requires:

Managed care plan” means any plan, regardless of form, offered or administered by any person or entity, including but not limited to an insurer governed by chapter 431, a mutual benefit society governed by chapter 432, a health maintenance organization governed by chapter 432D, a preferred provider organization, a point of service organization, a health insurance issuer, a fiscal intermediary, a payor, a prepaid health care plan, and any other mixed model, that provides for the financing or delivery of health care services or benefits to enrollees through:

(1) Arrangements with selected providers or provider networks to furnish health care services or benefits; and

(2) Financial incentives for enrollees to use participating providers and procedures provided by a plan; provided, that for the purposes of this chapter, an employee benefit plan shall not be deemed a managed care plan with respect to any provision of this chapter or to any requirement or rule imposed or permitted by this chapter which is superseded or preempted by federal law. 

Report Title: Emergency Contraceptives; Collaborative Pharmacist-Physician Agreement

Description: Allows pharmacists to dispense emergency contraceptives in accordance with approved procedures and protocols developed by a pharmacist and physician. (SD1)

HOUSE OF REPRESENTATIVES H.B. NO. 123, H.D. 1, S.D. 1, TWENTY-SECOND LEGISLATURE, 2003

A BILL FOR AN ACT RELATING TO THE PRACTICE OF PHARMACY.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

SECTION 1. In 2002, the legislature passed H.B. 1842, H.D. 1, S.D. 2, C.D. 1, which became Act 256, Session Laws of Hawaii 2002, to enable pharmacists to provide services in a broader range of clinical settings. The legislature noted that the increasing complexity of drug therapy required pharmacists to participate in the treatment of, and be the advocate for, the patient, in collaboration with other health care professionals.

Unintended pregnancies are a major public health concern affecting individuals and society in general. Each year, about three million five hundred thousand unintended pregnancies occur in this country, half of which result from contraceptive failure or inadequate contraceptive technique. According to the department of health's office of health status monitoring, in 2000, fifty-three per cent of pregnancies were unintended for women of all ages in Hawaii, and seventy-eight per cent were unintended among women under twenty years of age.

Emergency contraception is a highly cost-effective method of reducing unintended pregnancies, if taken within seventy-two hours after unprotected sex. However, in a statewide study conducted in early January of 2002, the Healthy Mothers, Healthy Babies Coalition of Hawaii learned that there are significant barriers to accessing emergency contraceptives in Hawaii within the recommended seventy-two hour time frame. The American College of Obstetricians and Gynecologists, American Academy of Pediatricians, American Public Health Association, and more than fifty other national organizations support increased access to emergency contraception.

The purpose of this Act is to enable pharmacists with appropriate training and who are working in collaboration with a physician to initiate emergency contraception oral drug therapy.

[Editor’s Note: Additions to existing law below are shown in bold; and deletions are in strikethrough.]

SECTION 2. Section 461-1, Hawaii Revised Statutes, is amended as follows:

1. By adding a new definition to be appropriately inserted and to read:

““Emergency contraception” means a drug that:

(1) Is used postcoitally;

(2) Prevents pregnancy by delaying ovulation, preventing fertilization of an egg, or preventing implantation of an egg in a uterus; and

(3) Is approved by the United States Food and Drug Administration.”

2. By amending the definition of “licensed medical doctor” and “practice of pharmacy” to read:

““Licensed [medical doctor”] physician” means a [medical doctor] physician licensed by the board of medical examiners pursuant to chapter 453 or [the board of osteopathic examiners under chapter] 460.

“Practice of pharmacy” means:

(1) The interpretation and evaluation of prescription orders; the compounding, dispensing, and labeling of drugs and devices (except labeling by a manufacturer, packer, or distributor of nonprescription drugs and commercially legend drugs and devices); the participation in drug selection and drug utilization reviews; the proper and safe storage of drugs and devices and the maintenance of proper records therefore; the responsibility for advising when necessary or where regulated, of therapeutic values, content, hazards, and use of drugs and devices;

(2) Performing the following procedures or functions as part of the care provided by and in concurrence with a “health care facility” and “health care service” as defined in section 323D-2, or a “pharmacy” or a licensed [medical doctor,] physician, or a “managed care plan” as defined in section 432E-1, in accordance with policies, procedures, or protocols developed collaboratively by health professionals, including physicians and surgeons, pharmacists, and registered nurses, and for which a pharmacist has received appropriate training required by these policies, procedures, or protocols:

(A) Ordering or performing routine drug therapy related patient assessment procedures;

(B) Ordering drug therapy related laboratory tests;

(C) Initiating emergency contraception oral drug therapy in accordance with a written collaborative agreement approved by the board, between a licensed physician and a pharmacist who has received appropriate training that includes programs approved by the American Council of Pharmaceutical Education (ACPE), curriculum-based programs from an ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board of pharmacy;

[(C)] (D) Administering drugs orally, topically, or by injection, pursuant to the patient’s licensed [medical doctor’s] physician's order, by a pharmacist having appropriate training that includes programs approved by the [American Council of Pharmaceutical Education (]ACPE[)], curriculum-based programs from an [American Council of Pharmaceutical Education accredited] ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board of pharmacy;

[(D)] (E) Administering immunizations by injection to persons eighteen years of age or older, by a pharmacist having appropriate training that includes programs approved by the [American Council of Pharmaceutical Education,] ACPE, curriculum-based programs from an [American Council of Pharmaceutical Education accredited] ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board of pharmacy;
[(E)] (F) As authorized by a licensed [medical doctor’s] physician's written instructions, initiating or adjusting the drug regimen of a patient pursuant to an order or authorization made by the patient’s licensed [medical doctor] physician and related to the condition for which the patient has been seen by the licensed [medical doctor;] physician; provided that the pharmacist shall issue written notification to the patient’s licensed [medical doctor] physician or enter the appropriate information in an electronic patient record system shared by the licensed [medical doctor,] physician, within twenty-four hours;

[(F)] (G) Transmitting a valid prescription to another pharmacist for the purpose of filling or dispensing; or

[(G)] (H) Providing consultation, information, or education to patients and health care professionals based on the pharmacist’s training and for which no other licensure is required; and

(3) The offering or performing of those acts, services, operations, or transactions necessary in the conduct, operation, management, and control of pharmacy.”

SECTION 3. Section 431:10A-116.6, Hawaii Revised Statutes, is amended by amending subsection (d) to read as follows:

“(d) For purposes of this section:

“Contraceptive services” means physician-delivered, physician-supervised, physician assistant–delivered, nurse practitioner-delivered, certified nurse midwife-delivered, [or] nurse-delivered, or pharmacist-delivered medical services intended to promote the effective use of contraceptive supplies or devices to prevent unwanted pregnancy.

“Contraceptive supplies” means all United States Food and Drug Administration-approved contraceptive drugs or devices used to prevent unwanted pregnancy.”

SECTION 4. Section 431:10A-116.7, Hawaii Revised Statutes, is amended by amending subsection (g) to read as follows:

“(g) For purposes of this section:

“Contraceptive services” means physician-delivered, physician-supervised, physician assistant-delivered, nurse practitioner-delivered, certified nurse midwife-delivered, [or] nurse-delivered, or pharmacist-delivered medical services intended to promote the effective use of contraceptive supplies or devices to prevent unwanted pregnancy.

“Contraceptive supplies” means all United States Food and Drug Administration-approved contraceptive drugs or devices used to prevent unwanted pregnancy.”

SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored (and bolded here--Editor’s Note.)

SECTION 6. This Act shall take effect upon its approval.

[Enacted as Act 201 on June 24, 2003 by signature of the Governor.]

 

HAWAII REGULATIONS

HAWAII ADMINISTRATIVE RULES

TITLE 16 - DEPARTMENT OF COMMERCE AND CONSUMER AFFAIRS

CHAPTER 95 - PHARMACISTS AND PHARMACIES

§16-95-82 Valid prescriptions.

(a) A pharmacist may fill and dispense prescriptions provided the prescription is valid. A valid prescription shall be legibly written and contain, at the minimum, the following information:

* * *

(6) The room number and route of administration if the patient is in an

institutional facility . . .

[Eff and comp 12/24/92] (Auth: HRS  461-4.5) (Imp: HRS  461-11, 461-13) Historical note:  16-95-82 is based in part upon  16-95-9 and 16- 95-10. [Eff 5/16/64; am and ren  16-95-9, 16-95-10, 6/22/81; R 12/24/92]

§16-95-93 Records of dispensing.

(a) Records of dispensing for original

and refill prescriptions are to be made and kept by pharmacies for five years and

shall include, but not be limited to, the following:

* * *

(b) An institutional pharmacy will have fulfilled the requirements of this section if the information required by paragraphs (1) to (4) of subsection (a) is kept on accurate patient profiles or medication administration records showing all drugs administered to the patient for five years; and the institutional facility keeps the original patient charts evidencing the prescription orders and medication administration records in the institutional facility’s files for at least five years.

[Eff and comp 12/24/92] (Auth: HRS §461-4.5) (Imp: HRS §§461-10, 461-11, 461-13)

Back to top

The state comparison information above was adapted from a study conducted by the American Pharmacists Association and commissioned by the Pharmacy Access Partnership.

< Back to State Profiles

About UsEC & PharmaciesState ProfilesLegislationResourcesGet InvolvedHomeSite Map

© 2008 Pharmacy Access Partnership